CN1054773C - Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome - Google Patents
Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome Download PDFInfo
- Publication number
- CN1054773C CN1054773C CN96106390A CN96106390A CN1054773C CN 1054773 C CN1054773 C CN 1054773C CN 96106390 A CN96106390 A CN 96106390A CN 96106390 A CN96106390 A CN 96106390A CN 1054773 C CN1054773 C CN 1054773C
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- chinese patent
- arthromyodynia
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese patent medicine for treating arthromyodynia, which is characterized in that raw materials comprising angelica, milkvetch root, hemlock parsley, largeleaf gentian root, leopard bones, curare, fourstamen stephania root, frankincense, myrrh, clematis root, cassia twigs, panax notoginseng, whole worms, stiff silkworms, himalayan teasel root, eucommia bark, safflower, kusnezoff monkshood root, musk, ledebouriella root, notoptetygium root, indian madder root, long-noded pit vipers, fresh ginger, red peony roots, dahurian angelica and radix glycyrrhiza are prepared into oral Chinese patent medicines by a conventional preparation method. The medicine finds out the basic cause of arthromyodynia, specifically the arthromyodynia is mainly caused by wind, cold, wet and mixed factors. The method has the clinical effective rate of 87% and has no toxic or side effect.
Description
The present invention relates to a kind of medicine for the treatment of arthromyodynia, specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Arthromyodynia is because exopathogen invasions such as human feeling's wind, cold, wet, heat cause the impatency meridians, and QI and blood can not freely be transported, thus limbs joint pain takes place, that stretch in the joint is unfavorable, influences a kind of clinical manifestation of normal activity.Arthromyodynia is traditional Chinese medical science predicate commonly used, and in conjunction with modern medicine, it can comprise such as rheumatism, rheumatoid arthritis, gout, peripheral neuritis, sciatica, diseases such as osteoarthritis and ankylosing spondylitis.
Because human body is being suffered from when stating disease all with similar symptom, so the sickness rate of arthromyodynia can't accurately be added up.With the rheumatoid arthritis is example, and its sickness rate is about 2 ‰ abroad, and domestic being about about 1 ‰, about 1,600,000 people of this patient (" commonly encountered diseases tcm clinical practice therapeutic advance ", China Traditional Chinese Medicine Publishing House, version in 1991,93 pages are suffered from by China.)
Because of the etiology unknown of above-mentioned disease, so doctor trained in Western medicine does not still have specific short, generally with bigcatkin willow acid supplement or hormone medicine treatment, its effect is undesirable and side effect is big, therefore, the advantage of the performance traditional Chinese medical science, inquiring into the Chinese medicine method is a valuable way.
Purpose of the present invention aims to provide the Chinese patent medicine of the little treatment arthromyodynia of a kind of good effect, side effect.
Solution of the present invention is with reference to TCM Document and numerous doctor family form through inventor's clinical research for many years again the achievement in research of arthromyodynia at all times.
The inventor thinks, arthromyodynia is because of wind, cold, wet assorted to causing a disease, according to theory of Chinese medical science, the generation of clinical symptoms all is obstructed relevant with blockage of main and collateral channels, blood vessels, though arthromyodynia is divided multiple medicine typings such as wind, cold, wet, heat, traditional prescription of successive dynasties medical science also emphasizes particularly on different fields, but it will be argued that too much typing causes difficulty to medication on the contrary.
Therefore, it is the main rule of treatment that the inventor proposes " promoting blood circulation and stopping pain is searched the wind damp eliminating for dispelling cold by warming the meridian, channels sootheing and network vessel quickening ", has caught the principal contradiction of assertive evidence, is fit to the various typings of arthromyodynia.
Chinese patent medicine of the present invention adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Sinensis 18-22b Radix Astragali 45-55b Rhizoma Chuanxiong 18-22b Radix Gentianae Macrophyllae 22-28b
Os pardi 14-18b Semen Strychni 22-28b Radix Stephaniae Tetrandrae 22-28b Olibanum 10-14b
Myrrha 10-14b Radix Clematidis 10-14b Ramulus Cinnamomi 16-20b Radix Notoginseng 21-27b
Scorpio 16-20b Bombyx Batryticatus 18-22b Radix Dipsaci 18-22b Cortex Eucommiae 27-33b
Flos Carthami 6-10b Radix Aconiti Kusnezoffii 27-33b Moschus 0.5-2b Radix Saposhnikoviae 13-17b
Rhizoma Et Radix Notopterygii 21-27b Radix Rubiae 36-44b Agkistrodon 8-12 bar Rhizoma Zingiberis Recens 20-24b
Radix Paeoniae Rubra 32-38b Radix Angelicae Dahuricae 32-38b Radix Glycyrrhizae 32-38b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Ramulus Cinnamomi in the side, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, Rhizoma Zingiberis Recens, the Radix Angelicae Dahuricae all have the dispelling cold by warming the meridian effect; Radix Aconiti Kusnezoffii contains aconitine, and the local anesthesia effect is arranged, and animal experiment has antiinflammatory, analgesia function; Radix Gentianae Macrophyllae, Radix Dipsaci, Cortex Eucommiae dredge the meridian passage; Semen Strychni contains brucine, can improve striate expanding ability; The effect of Moschus blood circulation promoting and dispersing pathogen accumulation is obvious; Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Flos Carthami blood circulation promoting and blood stasis dispelling; Olibanum, Myrrha promoting blood circulation and stopping pain; Bombyx Batryticatus, the pain relieving of Radix Saposhnikoviae endogenous wind stopping; The existing raising body immune function of the Radix Astragali can improve blood circulation again; Antibacterial, blood stasis dispelling effect that Radix Rubiae has; Radix Notoginseng can increase blood circulation, and haemolysis is arranged; Radix Stephaniae Tetrandrae, Radix Clematidis, Scolopendra, Agkistrodon are the product of traditional relieving convulsion, active, damp eliminating; Os pardi substitutes traditional Os Tigris, gets its Shujin eliminating stagnation effect; Radix Glycyrrhizae can be concocted all medicines.
The property of medicine of above medicine meets the principle of medication of the traditional Chinese medical science to arthromyodynia, wherein the pharmacological action of most flavour of a drug by experiment confirm (referring to " the national Chinese herbal medicine compilation " first volume, the People's Health Publisher, 1986 the 1st edition).
Routine arthromyodynia patient all obtained promising result surplus the inventor once treated 4000 with this medicine, did not find toxic and side effects in the medication.Be the curative effect statistics after 200 three courses of treatment of routine patient's medication (three months) of recent statistics below, wherein rheumatism, patient with rheumatoid arthritis 112 examples, patient with gout 24 examples, peripheral neuritis patient's 18 examples, patients with ankylosing spondylitis 16 examples, sciatic neuritis patient 19 examples, other 11 example.
Criterion of therapeutical effect:
Produce effects---treat three courses of treatment after disease sites pain stop, the joint can be bent and stretched,
The energy normal activity, or arthroncus is eliminated.Progressive---treatment back disease sites pain relief, limb activity before the treatment to some extent
Improve.Invalid---no change before and after the treatment.
200 routine arthromyodynia curative effect statistical tables
| Produce effects | Progressive | Invalid | Subtotal | |
| Rheumatism, rheumatoid arthritis | 37 | 67 | 8 | 112 |
| Gout | 8 | 10 | 6 | 24 |
| Peripheral neuritis | 6 | 9 | 3 | 18 |
| Ankylosing spondylitis | 4 | 8 | 4 | 16 |
| Sciatic neuritis | 9 | 8 | 2 | 19 |
| Other | 2 | 6 | 3 | 11 |
| Amount to | 66 (33％) | 108 (54％) | 26 (13％) | 200 |
The present invention has caught the basic cause of disease of arthromyodynia, think mainly be wind, cold, wet assorted to and cause a disease, so be the principles of formulating prescriptions with " promoting blood circulation and stopping pain is searched the wind damp eliminating for dispelling cold by warming the meridian, channels sootheing and network vessel quickening ".From above-mentioned curative effect statistical table as can be known, this medicine is 87% (wherein obvious effective rate 33%, progressive rate 54%) to the total effective rate of doing well,improving, inefficiency 13%, and do not find toxic and side effects.So the present invention has curative effect height, advantage that toxic and side effects is little.
Embodiment 1, and present embodiment adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Sinensis 20b Radix Astragali 50b Rhizoma Chuanxiong 20b Radix Gentianae Macrophyllae 25b
Os pardi 16b Semen Strychni 25b Radix Stephaniae Tetrandrae 25b Olibanum 12b
Myrrha 12b Radix Clematidis 12b Ramulus Cinnamomi 18b Radix Notoginseng 24b
Scorpio 18b Bombyx Batryticatus 20b Radix Dipsaci 20b Cortex Eucommiae 30b
Flos Carthami 8b Radix Aconiti Kusnezoffii 30b Moschus 1b Radix Saposhnikoviae 15b
10 Rhizoma Zingiberis Recens 22b of Rhizoma Et Radix Notopterygii 24b Radix Rubiae 40b Agkistrodon
Radix Paeoniae Rubra 35b Radix Angelicae Dahuricae 35b Radix Glycyrrhizae 35b
Above-mentioned Chinese medicine raw materials by weight proportion is made close ball or powder type oral Chinese patent medicine.
Method for making:
In the above-mentioned 27 flavor medicines, be the toxicity that lowers Semen Strychni, with stir-baking with sand to its colour changed into yellow (about 270 ℃, 3 minutes); Radix Aconiti Kusnezoffii is soaked in water earlier to the no dried heart, adds water boil 5 hours more in addition, drying, all the other Chinese medicines together with finished Semen Strychni, Radix Aconiti Kusnezoffii grind to the powder altogether powder.
Dosage form: 1, close ball: by " contained close ball method for making in the Chinese pharmacopoeia, above-mentioned loosing
Agent adds an amount of Mel and makes pill, and every ball weighs 9 grams;
2, powder: above-mentioned powder is packed in the plastic bag, sealing, every bag heavy 5 gram.
Function: dispelling cold by warming the meridian, channels sootheing and network vessel quickening, promoting blood circulation and stopping pain is searched the wind damp eliminating.
Cure mainly: disease such as limbs pain, joint joint stuffiness, limitation of activity or the arthroncus that causes because of rheumatism, rheumatoid arthritis, gout, peripheral neuritis, sciatic neuritis and ankylosing spondylitis etc. is scorching hot.
Obey twice usage: pill---every day, each 2 balls, and eliminating cold for resuscitation water send down;
Obey powder---every day 3 times, each 5 grams, eliminating cold for resuscitation water send down;
More than serveing on one month is a course of treatment, three the course of treatment observe the curative effect.
Embodiment 2, and present embodiment adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Sinensis 18b Radix Astragali 45b Rhizoma Chuanxiong 18b Radix Gentianae Macrophyllae 22b
Os pardi 14b Semen Strychni 22b Radix Stephaniae Tetrandrae 22b Olibanum 10b
Myrrha 10b Radix Clematidis 10b Ramulus Cinnamomi 16b Radix Notoginseng 21b
Scorpio 16b Bombyx Batryticatus 18b Radix Dipsaci 18b Cortex Eucommiae 27b
Flos Carthami 6b Radix Aconiti Kusnezoffii 27b Moschus 0.5b Radix Saposhnikoviae 13b
8 Rhizoma Zingiberis Recens 20b of Rhizoma Et Radix Notopterygii 21b Radix Rubiae 36b Agkistrodon
Radix Paeoniae Rubra 32b Radix Angelicae Dahuricae 32b Radix Glycyrrhizae 32b
Above-mentioned Chinese medicine raw materials by weight proportion is made close ball or powder type oral Chinese patent medicine.
Embodiment 3, and present embodiment adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Sinensis 22b Radix Astragali 55b Rhizoma Chuanxiong 22b Radix Gentianae Macrophyllae 28b
Os pardi 18b Semen Strychni 28b Radix Stephaniae Tetrandrae 28b Olibanum 14b
Myrrha 14b Radix Clematidis 14b Ramulus Cinnamomi 20b Radix Notoginseng 27b
Scorpio 20b Bombyx Batryticatus 22b Radix Dipsaci 22b Cortex Eucommiae 33b
Flos Carthami 10b Radix Aconiti Kusnezoffii 33b Moschus 2b Radix Saposhnikoviae 17b
12 Rhizoma Zingiberis Recens 24b of Rhizoma Et Radix Notopterygii 27b Radix Rubiae 44b Agkistrodon
Radix Paeoniae Rubra 38b Radix Angelicae Dahuricae 38b Radix Glycyrrhizae 38b
Above-mentioned Chinese medicine raw materials by weight proportion is made close ball or powder type oral Chinese patent medicine.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of arthromyodynia is characterized in that: this Chinese patent medicine adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Sinensis 18-22b Radix Astragali 45-55b Rhizoma Chuanxiong 18-22b Radix Gentianae Macrophyllae 22-28b
Os pardi 14-18b Semen Strychni 22-28b Radix Stephaniae Tetrandrae 22-28b Olibanum 10-14b
Myrrha 10-14b Radix Clematidis 10-14b Ramulus Cinnamomi 16-20b Radix Notoginseng 21-27b
Scorpio 16-20b Bombyx Batryticatus 18-22b Radix Dipsaci 18-22b Cortex Eucommiae 27-33b
Flos Carthami 6-10b Radix Aconiti Kusnezoffii 27-33b Moschus 0.5-2b Radix Saposhnikoviae 13-17b
Rhizoma Et Radix Notopterygii 21-27b Radix Rubiae 36-44b Agkistrodon 8-12 bar Rhizoma Zingiberis Recens 20-24b
Radix Paeoniae Rubra 32-38b Radix Angelicae Dahuricae 32-38b Radix Glycyrrhizae 32-38b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, the Chinese patent medicine of treatment arthromyodynia according to claim 1 is characterized in that: described Chinese patent medicine adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Radix Angelicae Sinensis 20b Radix Astragali 50b Rhizoma Chuanxiong 20b Radix Gentianae Macrophyllae 25b
Os pardi 16b Semen Strychni 25b Radix Stephaniae Tetrandrae 25b Olibanum 12b
Myrrha 12b Radix Clematidis 12b Ramulus Cinnamomi 18b Radix Notoginseng 24b
Scorpio 18b Bombyx Batryticatus 20b Radix Dipsaci 20b Cortex Eucommiae 30b
Flos Carthami 8b Radix Aconiti Kusnezoffii 30b Moschus 1b Radix Saposhnikoviae 15b
10 Rhizoma Zingiberis Recens 22b of Rhizoma Et Radix Notopterygii 24b Radix Rubiae 40b Agkistrodon
Radix Paeoniae Rubra 35b Radix Angelicae Dahuricae 35b Radix Glycyrrhizae 35b
Above-mentioned Chinese medicine raw materials by weight proportion is made close ball or powder type oral Chinese patent medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96106390A CN1054773C (en) | 1996-06-11 | 1996-06-11 | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96106390A CN1054773C (en) | 1996-06-11 | 1996-06-11 | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1140086A CN1140086A (en) | 1997-01-15 |
| CN1054773C true CN1054773C (en) | 2000-07-26 |
Family
ID=5119125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96106390A Expired - Fee Related CN1054773C (en) | 1996-06-11 | 1996-06-11 | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1054773C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1318053C (en) * | 2005-04-15 | 2007-05-30 | 刘大宏 | Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100406033C (en) * | 2003-04-09 | 2008-07-30 | 兰加松 | Medicated bag for curing spur disease |
| EP1855702A2 (en) * | 2004-06-09 | 2007-11-21 | Shenzhen Qianrenren Sci. & Tech. Development Co. | Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same |
| CN1985931B (en) * | 2006-12-14 | 2010-10-06 | 石锐 | Chinese medicine for treating bi syndrome |
| CN101433647B (en) * | 2008-12-14 | 2011-06-08 | 白翼铭 | Plaster for treating femoral head necrosis and preparation method thereof |
| CN102240331B (en) * | 2011-03-24 | 2013-07-24 | 刘圣根 | Ointment mainly for treating rheumatoid arthritis |
| CN103083609B (en) * | 2011-10-28 | 2014-12-31 | 刘亚芝 | Traditional Chinese medicine for treating cervical spondylosis, lumbar intervertebral disc herniation and ankylosing spondylitis |
| CN102488768B (en) * | 2011-12-03 | 2014-04-16 | 王宝香 | Traditional Chinese medicine for treating gout |
| CN104095922A (en) * | 2014-08-06 | 2014-10-15 | 许继臣 | Chinese medicinal composition for treating arthralgia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076120A (en) * | 1993-01-19 | 1993-09-15 | 王来运 | Medical liquid for relaxing tendons and joints |
| CN1115240A (en) * | 1994-07-19 | 1996-01-24 | 李子义 | Pill for stimulating circulation of blood and causing muscles and joints to relax |
-
1996
- 1996-06-11 CN CN96106390A patent/CN1054773C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1076120A (en) * | 1993-01-19 | 1993-09-15 | 王来运 | Medical liquid for relaxing tendons and joints |
| CN1115240A (en) * | 1994-07-19 | 1996-01-24 | 李子义 | Pill for stimulating circulation of blood and causing muscles and joints to relax |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1318053C (en) * | 2005-04-15 | 2007-05-30 | 刘大宏 | Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1140086A (en) | 1997-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1150922C (en) | Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia | |
| CN1229658A (en) | Compound sanbi medicinal liquor for treating gout | |
| CN101053632A (en) | Traditional Chinese medicine for treating thromboangitis obliterans | |
| CN1943689A (en) | A Chinese traditional medicinal composition for treatment of wind-heat type common cold and its preparation method | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN1056775C (en) | Drug for curing stone of urinary system | |
| CN1876074A (en) | A constipation-treating medicament and preparation method thereof | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1682811A (en) | Strengthening spine and bone pill ofr treating rigid spondylitis | |
| CN1053587C (en) | Chinese patent drug | |
| CN1055226C (en) | Medicine for curing trichomadesis and its preparation method | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1055220C (en) | Chinese drug for treatment of hemiplegia | |
| CN1053363C (en) | Oral liquid of shengxueyin | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1099876C (en) | Medicine for curing psoriasis | |
| CN1173718C (en) | Medicine for curing lupus erythematosus etc. immune diseases induced diseases | |
| CN1030373C (en) | Medicine for waist rheumatism | |
| CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1290551C (en) | Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone | |
| CN1302639A (en) | Tendon-conditioning analgetic | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
| CN1176108A (en) | Kidney-warming and Yang-activating medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |